STOCK TITAN

Cemex (NYSE: CX) gets EU antitrust Statement of Objections on admixtures

(Neutral)
(Neutral)
Form Type
6-K

Rhea-AI Filing Summary

Cemex, S.A.B. de C.V. reports that the European Commission has issued a Statement of Objections in ongoing antitrust investigations related to its admixtures activity in France and Germany within the construction chemicals sector.

Cemex explains that its European admixtures production is mainly for internal consumption, with insignificant third-party sales. The company does not agree with the preliminary findings and will formally respond. As of July 20, 2026, Cemex states it cannot assess the likely outcome or whether an adverse resolution would have a material adverse impact on its results of operations, liquidity and financial condition.

Positive

  • None.

Negative

  • None.
Statement of Objections regulatory
"Cemex received a Statement of Objections from the European Commission"
antitrust investigations regulatory
"regarding the previously disclosed antitrust investigations that initiated in 2023"
Antitrust investigations are probes by government regulators into whether a company’s conduct unfairly limits competition—like a referee checking for fouls that give one player an illegal advantage. For investors they matter because findings can lead to fines, limits on mergers, forced changes to business practices, or even divestitures, all of which can reduce revenue, raise costs, damage reputation, and create legal uncertainty about a company’s future earnings.
European Commission regulatory
"received a Statement of Objections from the European Commission that relates to Cemex’s admixtures"
The European Commission is the executive arm of the European Union that proposes and enforces EU laws, manages the EU budget, and represents the bloc in trade and regulatory matters. It matters to investors because its decisions on regulations, competition enforcement, approvals and fines can reshape entire industries, affect company profits and risk, and change where capital flows—much like a referee and rulemaker whose calls influence how the game is played.
results of operations, liquidity and financial condition financial
"if it would have a material adverse impact on Cemex’s results of operations, liquidity and financial condition"
admixtures technical
"relates to Cemex’s admixtures activity in France and Germany"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What did Cemex (CX) disclose about the European Commission investigation?

Cemex disclosed that the European Commission issued a Statement of Objections in antitrust investigations concerning its admixtures activity in France and Germany. The company does not agree with the preliminary findings and plans to respond through the established procedure.

Which Cemex (CX) business is affected by the European Commission’s Statement of Objections?

The Statement of Objections relates to Cemex’s admixtures activity in France and Germany within the construction chemicals sector. Cemex notes that, in Europe, it produces admixtures mainly for internal use, with insignificant third-party sales in this area.

Does Cemex (CX) agree with the European Commission’s preliminary findings?

Cemex explicitly states it does not agree with the preliminary findings contained in the European Commission’s Statement of Objections. The company plans to formally respond in due course as part of the ongoing administrative process before the Commission.

Can Cemex (CX) estimate the financial impact of the EU investigation?

As of July 20, 2026, Cemex says it is not able to assess the likely outcome of the investigation or whether an adverse resolution would have a material adverse impact on its results of operations, liquidity and financial condition.

How significant are Cemex’s third-party admixtures sales in Europe?

Cemex states that, where it produces admixtures in Europe, this is done primarily for internal consumption. As a result, its third-party sales are described as insignificant, which may influence the potential business impact of the European Commission’s investigation.
 
 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 6-K

 

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 or 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of July 2026

Commission File Number: 001-14946

 

 

Cemex, S.A.B. de C.V.

(Translation of Registrant’s name into English)

 

 

Avenida Ricardo Margáin Zozaya #325, Colonia Valle del Campestre,

San Pedro Garza García, Nuevo León 66265, México

(Address of principal executive offices)

 

 

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F ☒    Form 40-F ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐

 

 
 


Contents

Cemex, S.A.B. de C.V. (“Cemex”) (NYSE: CX) informed today that, regarding the previously disclosed antitrust investigations that initiated in 2023 in the construction chemicals sector, Cemex received a Statement of Objections (“SO”) from the European Commission (“EC”) that relates to Cemex’s admixtures activity in France and Germany. The fact that this investigation is being conducted does not mean that the EC has finally concluded that Cemex has not complied with the law. As Cemex has disclosed in the past, to the extent that Cemex produces admixtures in Europe, Cemex does so primarily for internal consumption and consequently has insignificant third-party sales. Cemex does not agree with the preliminary findings contained in the SO and will formally respond in due time as part of the ongoing process. As of July 20, 2026, due to the current stage of this investigation, Cemex is not able to assess the likely outcome of the investigation or, if the matter is adversely resolved against Cemex, if it would have a material adverse impact on Cemex’s results of operations, liquidity and financial condition.


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, Cemex, S.A.B. de C.V. has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. 

 

       

Cemex, S.A.B. de C.V.

        (Registrant)
Date: July 20, 2026       By:  

/s/ Jaime Martínez Merla

        Name: Jaime Martínez Merla
        Title:  Chief Comptroller

 

3